NW-8-184

N/A

Report date: 2023/08/30 12:01:13
NME

Base Information

Drug NameNW-8-184
Drug Alias NameNW-8-184
ClassificationOther
Mechanisms of ActionProteolysis
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewave Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesNewave Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A